(IPGP) IPG Photonics - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US44980X1090

Stock: Fiber Lasers, Fiber Amplifiers, Diode Lasers, Welding Systems, Processing Heads

Total Rating 65

Risk 84

Buy Signal 1.33

Semiconductor Equipment & Materials » Electronic Manufacturing Services
Age: 19.2y

Market Cap: 4,176m
Avg Trading Vol: 33.1M USD

ATR: 3.91%
Peers RS (IBD): 57.14

EPS (Earnings per Share)

EPS CAGR: -5.60%
EPS Trend: -55.7%

Last SUE: -0.09
Qual. Beats: 0

Revenue

Rev. CAGR: -9.49%
Rev. Trend: -92.9%

Last SUE: 1.10
Qual. Beats: 2

Risk 5d forecast
Volatility	53.2%
Relative Tail Risk	-4.89%

Reward TTM
Sharpe Ratio	1.08
Alpha	29.56

Character TTM
Beta	1.661
Beta Downside	1.638

Drawdowns 3y
Max DD	64.44%
CAGR/Max DD	-0.01

Description: IPGP IPG Photonics January 12, 2026

IPG Photonics (NASDAQ:IPGP) designs, manufactures, and sells high-performance fiber, solid-state, and diode lasers plus related accessories (e.g., delivery fibers, beam switches, chillers) for materials processing, medical devices, and advanced industrial applications. Its product portfolio spans hybrid green/UV fiber-solid-state lasers, high-energy pulsed systems, tunable and single-frequency sources, and turnkey solutions such as LightWELD handheld welders, multi-axis cutting heads, and robotic welding automation.

In FY 2023 the company reported roughly $1.7 billion in revenue, with a 12 % year-over-year increase driven primarily by automotive laser-welding sales and expanding demand from the renewable-energy and EV-battery sectors. The fiber-laser market is projected to grow at a CAGR of ~10 % through 2029, underpinned by rising capex in semiconductor equipment and a shift toward high-precision, low-cost manufacturing. IPGP’s gross margin has hovered around 55 %, but is sensitive to raw-material pricing for rare-earth dopants and to fluctuations in the global supply chain for high-purity optical fibers.

For a deeper quantitative assessment, you may find ValueRay’s IPGP analyst page useful.

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income: 25.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.02 > 0.02 and ΔFCF/TA -6.10 > 1.0
NWC/Revenue: 126.7% < 20% (prev 132.1%; Δ -5.39% < -1%)
CFO/TA 0.05 > 3% & CFO 120.3m > Net Income 25.6m
Net Debt (-328.7m) to EBITDA (98.6m): -3.33 < 3
Current Ratio: 6.72 > 1.5 & < 3
Outstanding Shares: last quarter (42.6m) vs 12m ago -2.92% < -2%
Gross Margin: 38.68% > 18% (prev 0.35%; Δ 3833 % > 0.5%)
Asset Turnover: 40.69% > 50% (prev 44.23%; Δ -3.54% > 0%)
Interest Coverage Ratio: -1.88 > 6 (EBITDA TTM 98.6m / Interest Expense TTM -19.6m)

Altman Z'' 10.00

A: 0.51 (Total Current Assets 1.43b - Total Current Liabilities 213.4m) / Total Assets 2.38b
B: 1.11 (Retained Earnings 2.63b / Total Assets 2.38b)
C: 0.02 (EBIT TTM 36.9m / Avg Total Assets 2.37b)
D: 9.39 (Book Value of Equity 2.59b / Total Liabilities 276.2m)
Altman-Z'' Score: 16.93 = AAA

Beneish M -2.73

DSRI: 1.12 (Receivables 169.1m/163.5m, Revenue 963.6m/1.04b)
GMI: 0.90 (GM 38.68% / 34.75%)
AQI: 1.64 (AQ_t 0.14 / AQ_t-1 0.08)
SGI: 0.93 (Revenue 963.6m / 1.04b)
TATA: -0.04 (NI 25.6m - CFO 120.3m) / TA 2.38b)
Beneish M-Score: -2.73 (Cap -4..+1) = A

What is the price of IPGP shares?

As of February 08, 2026, the stock is trading at USD 109.61 with a total of 529,517 shares traded.
Over the past week, the price has changed by +18.61%, over one month by +37.93%, over three months by +22.13% and over the past year by +54.77%.

Is IPGP a buy, sell or hold?

IPG Photonics has received a consensus analysts rating of 3.11. Therefor, it is recommend to hold IPGP.

StrongBuy: 2
Buy: 0
Hold: 5
Sell: 1
StrongSell: 1

What are the forecasts/targets for the IPGP price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	96.9	-11.6%
Analysts Target Price	96.9	-11.6%
ValueRay Target Price	119.1	8.6%

IPGP Fundamental Data Overview February 05, 2026

P/E Trailing = 179.8545
P/E Forward = 68.0272
P/S = 4.334
P/B = 1.9797
P/EG = 2.52
Revenue TTM = 963.6m USD
EBIT TTM = 36.9m USD
EBITDA TTM = 98.6m USD
Long Term Debt = 17.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.90m USD (from shortTermDebt, last quarter)
Debt = 17.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -328.7m USD (from netDebt column, last quarter)
Enterprise Value = 3.32b USD (4.18b + Debt 17.4m - CCE 870.4m)
Interest Coverage Ratio = -1.88 (Ebit TTM 36.9m / Interest Expense TTM -19.6m)
EV/FCF = 91.69x (Enterprise Value 3.32b / FCF TTM 36.2m)
FCF Yield = 1.09% (FCF TTM 36.2m / Enterprise Value 3.32b)
FCF Margin = 3.76% (FCF TTM 36.2m / Revenue TTM 963.6m)
Net Margin = 2.66% (Net Income TTM 25.6m / Revenue TTM 963.6m)
Gross Margin = 38.68% ((Revenue TTM 963.6m - Cost of Revenue TTM 590.9m) / Revenue TTM)
Gross Margin QoQ = 39.48% (prev 37.32%)
Tobins Q-Ratio = 1.40 (Enterprise Value 3.32b / Total Assets 2.38b)
Interest Expense / Debt = 197.0% (Interest Expense 34.2m / Debt 17.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = 29.2m (EBIT 36.9m * (1 - 21.00%))
Current Ratio = 6.72 (Total Current Assets 1.43b / Total Current Liabilities 213.4m)
Debt / Equity = 0.01 (Debt 17.4m / totalStockholderEquity, last quarter 2.10b)
Debt / EBITDA = -3.33 (Net Debt -328.7m / EBITDA 98.6m)
Debt / FCF = -9.07 (Net Debt -328.7m / FCF TTM 36.2m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.08% (Net Income 25.6m / Total Assets 2.38b)
RoE = 1.24% (Net Income TTM 25.6m / Total Stockholder Equity 2.07b)
RoCE = 1.77% (EBIT 36.9m / Capital Employed (Equity 2.07b + L.T.Debt 17.4m))
RoIC = 1.41% (NOPAT 29.2m / Invested Capital 2.07b)
WACC = 11.99% (E(4.18b)/V(4.19b) * Re(12.04%) + (debt cost/tax rate unavailable))
Discount Rate = 12.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.49%
[DCF Debug] Terminal Value 60.09% ; FCFF base≈93.6m ; Y1≈75.5m ; Y5≈52.1m
Fair Price DCF = 21.03 (EV 557.1m - Net Debt -328.7m = Equity 885.8m / Shares 42.1m; r=11.99% [WACC]; 5y FCF grow -23.12% → 2.90% )
EPS Correlation: -55.73 | EPS CAGR: -5.60% | SUE: -0.09 | # QB: 0
Revenue Correlation: -92.93 | Revenue CAGR: -9.49% | SUE: 1.10 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.27 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=6
EPS next Year (2026-12-31): EPS=1.59 | Chg30d=+0.044 | Revisions Net=+1 | Growth EPS=+30.1% | Growth Revenue=+7.8%

Additional Sources for IPGP Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle